跳至主要内容
临床试验/NCT03235271
NCT03235271已完成不适用

Non-Blinded Data Collection Pilot Study of Acute Stroke Using the Brainpulse™

Jan Medical, Inc.3 个研究点 分布在 1 个国家目标入组 252 人开始时间: 2017年9月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
252
试验地点
3
主要终点
Compare Stroke subject recordings with non-stroke subject recordings

研究概览

简要总结

The aim of this pilot study is to collect data on stroke patients and non-stroke patients or healthy volunteers using the BrainPulse Stroke Monitor. Subject characteristics, diagnostic procedures and clinical outcomes will be documented as part of the data collected to assess the clinical utility of the BrainPulse device. All eligible patients and healthy volunteers will be enrolled and assigned to a study Group based on confirmation of their diagnosis: Acute Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attack or No Stroke. The data collected from the BrainPulse will be compared across the different study groups in an attempt to distinguish stroke from other non-stroke conditions that present with similar symptoms and LVO from non-LVO types of strokes. Further assessments will also be made to evaluate if the BrainPulse can identify the presence of stroke.

详细描述

The study is a prospective, non-randomized, non-blinded, hospital-based study of patients presenting with acute stroke symptoms within 48 hours of symptom onset (last known normal or actual time) as evidenced by radiological imaging. The study will be executed in two parts: Study Phase I and Study Phase II. Each study phase will consist of the same sequence of events and study procedures. The first part of the study is designed to enroll a smaller sample size to evaluate the feasibility of incorporating the BrainPulse device in the Stroke patient care workflow.

Patients will be consecutively recruited and once patients have met eligibility, they will be assigned to one of the four study Groups based on their confirmed clinical diagnosis. Each subject will complete one BrainPulse recording before neuro-intervention and within four hours of IV pharmacologic intervention. All subjects will also complete comprehensive neurological, cognitive and NIH Stroke Scale (NIHSS) assessments. Additionally, Ischemic Stroke subjects (Group A) that receive neuro-intervention will complete one additional, and optional BrainPulse recording along with a neurological exam after intervention. If these procedures have been completed as part of standard of care, the data can be captured directly from the medical records. If such procedures were not conducted as part of hospital's standard of care, they will need to be completed for the purpose of the study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subjects 18 years or older
  • Patient undergoes or will undergo radiological imaging (CT/MR) as part of stroke evaluation (n/a for Group D2)
  • Demonstrated at least 1 of the following symptoms (n/a for Group D2):
  • Hemiparesis, monoparesis, or quadriparesis
  • Hemisensory deficits
  • Monocular/binocular visual loss
  • Visual field deficits
  • Facial droop
  • Severe and sudden onset of headache
  • Nausea, and/or vomiting
  • Altered or loss of consciousness
  • Imbalance/ Incoordination
  • Last known normal or actual time point, whichever is known, since commencement of symptoms < 48 hours prior to enrollment (n/a for Group D2)
  • Consent procedures followed per applicable IRB approvals at site

排除标准

  • Not a candidate for radiological imaging (CT/MR) or angiography (CTA/MRA/DSA) (n/a for Group D2)
  • Patient meets the hospital criteria for brain death
  • Wound or laceration on the head in the area of one of the BrainPulse sensors that would impede use of the BrainPulse device
  • Any serious medical, social or psychological condition that in the opinion of the investigator would disqualify a patient from participation
  • Symptoms due to head trauma
  • IV tPA commenced or completed > 4 hours ago
  • Any neuro-intervention commenced or completed between admission and time of enrollment
  • If does not satisfy the eligibility criteria for groups A, B, C, and D.

结局指标

主要结局

Compare Stroke subject recordings with non-stroke subject recordings

时间窗: 6 months

The primary endpoint in Part I of the study is to enroll and record BrainPulse data from 35 eligible subjects who present with classic stroke symptoms and either have a confirmed diagnosis of stroke or no stroke. The BrainPulse device will be used to analyze and compare the differences in signal characteristics between stroke, TIA and control subjects.

Compare differences in signal charactertistics between LVO stroke and all other subjects

时间窗: 12 months

BrainPulse signal of all subjects will be analyzed to compare the difference in signal characteristics between LVO stroke and all other subjects enrolled in the study.

次要结局

  • Compare Ischemic stroke subject recordings with hemorrhagic stroke or stroke mimic subject recordings(12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验